Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00458 | 4-nitrophenyl 2-(pyridin-2-yldisulfanyl)ethyl carbonate | 874302-76-8 |
| Inquiry | ||
| BADC-00459 | SPDP-PEG8-NHS | 1252257-56-9 |
| Inquiry | ||
| BADC-00460 | Pyridin-2-yldisulfanyl-PEG4-NHS | 1305053-43-3 |
| Inquiry | ||
| BADC-00463 | N-succinimidyl-6-(2-pyridyldithio)capronate | 1824718-79-7 |
| Inquiry | ||
| BADC-00464 | N-succinimidyl-5-(2-pyridyldithio)valerate | 317331-86-5 |
| Inquiry | ||
| BADC-00465 | 1-(4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 663599-00-6 |
| NO2-SPDMV-sulfo is a small molecule compound in the biomedical field. It is a potent drug that shows significant efficacy by selectively targeting key drug receptors. It has shown great promise in halting the progression of certain malignancies and inflammatory diseases. | Inquiry | |
| BADC-00469 | 1-(4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 663599-11-9 |
| Inquiry | ||
| BADC-00470 | 2,5-dioxopyrrolidin-1-yl 4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoate | 663599-10-8 |
| Inquiry | ||
| BADC-00471 | 3-(methylsulfonyl)-2,5-dioxopyrrolidin-1-yl 4-((5-nitropyridin-2-yl)disulfanyl)pentanoate | 890409-87-7 |
| Inquiry | ||
| BADC-00472 | 1-(4-((5-nitropyridin-2-yl)disulfanyl)pentanoyloxy)-2,5-ioxopyrrolidine-3-sulfonic acid | 663598-66-1 |
| Inquiry | ||
| BADC-00473 | 2,5-dioxopyrrolidin-1-yl 4-((5-nitropyridin-2-yl)disulfanyl)pentanoate | 663598-61-6 |
| Inquiry | ||
| BADC-00474 | 2,5-dioxo-1-(4-(pyridin-2-yldisulfanyl)pentanoyloxy)pyrrolidine-3-sulfonic acid | 452072-27-4 |
| Inquiry | ||
| BADC-00475 | 1-(2,5-dioxopyrrolidin-1-yloxy)-4-((5-nitropyridin-2-yl)disulfanyl)-1-oxobutane-2-sulfonic acid | 1193111-37-3 |
| Inquiry | ||
| BADC-00476 | 2,5-dioxopyrrolidin-1-yl 2-(dimethylamino)-4-(pyridin-2-yldisulfanyl)butanoate | 1193111-73-7 |
| Dimethylamine-SPDB is a small molecule biopharmaceutical compound. It inhibits viral replication and pathogenesis by targeting enzymes, demonstrating its prowess as a powerful antagonist of viral infections, including influenza and hepatitis. Furthermore, it holds great promise in the field of oncology, fighting malignant tumors by elastically destroying the growth and proliferation of malignant cells. | Inquiry | |
| BADC-00478 | 1-(4-((5-(dimethylcarbamoyl)pyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 663599-07-3 |
| DMAC-SPDB-sulfo is an effective small molecule reagent. Its efficacy is primarily due to its selective mediation of key enzyme cascades and receptor signaling pathways, which are critical for targeted disease progression. This breakthrough bioactive compound has great potential to intervene in specific diseases. | Inquiry | |
| BADC-00479 | 1-(4-((5-nitropyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 663598-89-8 |
| Inquiry | ||
| BADC-00480 | 3-(methylsulfonyl)-2,5-dioxopyrrolidin-1-yl 4-((5-nitropyridin-2-yl)disulfanyl)butanoate | 890409-86-6 |
| Inquiry | ||
| BADC-00482 | 2,5-dioxo-1-(4-(pyridin-2-yldisulfanyl)butanoyloxy)pyrrolidine-3-sulfonic acid | 1628113-16-5 |
| SPDB-sulfo is a small molecule compound. This compound is effective against bacterial invasion, including pneumonia, respiratory infections, and urinary tract infections. It exhibits its good antibacterial abilities. | Inquiry | |
| BADC-00483 | 2,5-dioxopyrrolidin-1-yl 4-((5-(dimethylcarbamoyl)pyridin-2-yl)disulfanyl)butanoate | 663599-05-1 |
| DMAC-SPDB is a bioactive compound. It blocks signaling pathways associated with cancer and inflammation, exerting its influence as a targeted enzyme inhibitor. Furthermore, it shows decent proficiency in regulating the harmonious balance of enzymatic reactions associated with metabolic dysfunction. | Inquiry | |
| BADC-00484 | N-succinimidyl 4-(5-nitro-pyridin-2-yldithio)-pentanoate | 663598-85-4 |
| Inquiry |
